Introduction: Detrusor hyperactivity is the leading cause of urinary dysfunction in Parkinson's disease (PD). There are few studies correlating PD clinical aspects with this autonomic feature. Methods: A cohort of 63 women with PD were prospectively examined for assessment of clinical aspects and disease severity using unified Parkinson's disease rating scale and Hoehn-Yahr scale, respectively. The urologic function was evaluated by the urodynamic study. Two groups were categorized at this time - groups with and without detrusor hyperactivity. After seven years, the same parameters were re-evaluated. Results: Progression of the disease on mental scores was found in the group with detrusor hyperactivity. On follow-up, clinical symptoms and severity did not show significant worsening between the groups. Conclusion: Detrusor hyperactivity is a frequent urodynamic finding in PD, and even though it is associated with dopaminergic dysfunction, it cannot be blamed as a factor of worsening motor performance, but is probably associated with poor cognitive and mental prognosis.719:00 AM591595Hawkes, C., The prodromal phase of sporadic Parkinson's disease: Does it exist and if so how long is it? (2008) Mov Disord, 23, pp. 1799-1807Schrag, A., Dodel, R., Spottke, A., Rate of clinical progression in Parkinson's disease. A prospective study (2007) Mov Disord, 22, pp. 938-945Magalhaes, M.V.M., Mendes, A., Silva, T., Disautonomy in idiopathic Parkinson's disease. Prevalence and natural history (1998) Mov Disord, 13 (2 SUPPL.), pp. S273Verbaan, D., Marinus, J., Visser, M., Patient reported autonomic symptoms in Parkinson's disease (2007) Neurology, 69, pp. 323-341Kosaka, K., Diffuse Lewy body disease in Japan (1990) J Neurol, 237, pp. 197-204Poewe, W., Clinical measures of progression in Parkinson's disease (2009) Mov Disord, 24 (SUPPL.), pp. S671-S676Braak, H., Müller, C.M., Rüb, U., Pathology associated with sporadic Parkinson's disease - where does it end? (2006) J Neural Transm, 70, pp. 89-97Selikhova, M., Williams, D.R., Kempster, P.A., A clinic-pathological study of subtypes in Parkinson's disease (2009) Brain, 132, pp. 2947-2957Winge, K., Nielsen, K., Bladder dysfunction in advanced Parkinson's disease (2012) Neurourol Urodyn, 31, pp. 1279-1283Uchiyama, T., Sakakibara, R., Yamamoto, T., Urinary dysfunction in early and untreated Parkinson's disease (2011) J Neurol Neurosurg Psychiatry, 82, pp. 1382-1386Araki, I., Kuno, S., Assessment of voiding dysfunction in Parkinson's disease by the International Prostate Symptom Score (2000) J Neurol Neurosurg Psychiatry, 68, pp. 429-433Sakakibara, R., Uchiyama, T., Yamanishi, T., Bladder and bowel dysfunction in Parkinson's disease (2008) J Neural Transm, 115, pp. 443-460Cardozo, L., Robinson, D., Special considerations in premenopausal and postmenopausal women with symptoms of overactive bladder (2002) Urology, 60 (1 SUPPL.), pp. S64-S71Abrams, P., Cardozo, L., Fall, M., The standardisation of terminology of lower urinary tract function: Report from the standardisation sub-committee of the International Continence Society (2002) Neurourol Urodyn, 21, pp. 167-178Palleschi, G., Pastore, A., Stocchi, F., Correlation between the overactive bladder questionnaire (OAB-q) and urodynamic data of Parkinson disease patients affected by neurogenic detrusor overactivity during antimuscarinic treatment (2006) Clin Neuropharmacol, 29, pp. 220-229Gomes, C.M., Arap, S., Trigo-Rocha, F., Voiding dysfunction and urodynamic abnormalities in elderly patients (2004) Rev Hosp Clín Fac Med S. Paulo, 59, pp. 206-215Winge, K., Friberg, L., Werdelin, L., Relationship between nigrostriatal dopaminergic degeneration, urinary symptoms, and bladder control in Parkinson's disease (2005) Eur J Neurol, 12, pp. 842-850Defreitas, G., Lemack, G., Zimmern, P., Distinguishing neurogenic from non-neurogenic detrusor overactivity: A urodynamic assessment of lower urinary tract symptoms in patients with and without Parkinson's disease (2003) Urology, 62, pp. 651-655Garnett, S., Abrams, P., The natural history of the overactive bladder and detrusor overactivity. A review of the evidence regarding the long-term outcome of the overactive bladder (2003) J Urology, 169, pp. 843-848Gershanik, O.S., Clinical problems in late-stage Parkinson's disease (2010) J Neurol, 257, pp. S288-S291Gibb, W.R., Lees, A.J., The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease (1988) J Neurol Neurosurg Psychiatry, 51, pp. 745-752(2000) Diagnostic and Statistical Manual of Mental Disorders, , 4th editionDSM-IVAmerican Psychiatric AssociationVanrooden, S., Colas, F., Martinez-Martin, P., Clinical subtypes of Parkinson's disease (2011) Mov Disords, 26, pp. 51-58Araki, I., Kuno, S., Assessment of voiding dysfunction in Parkinson's disease by the International Prostate Symptom Score (2000) J Neurol Neurosurg Psychiatry, 68, pp. 429-433Hashimoto, K., Oyama, T., Sugiyama, T., Neuronal excitation in the ventral tegmental area modulates the micturition reflex mediated via the dopamine D(1) and D(2) receptors in rats (2003) J Pharmacological Sci, 92, pp. 143-148Greffard, S., Verny, M., Bonnet, A., Motor score of the unified Parkinson disease rating scale as a good predictor of Lewy body-associated neuronal loss in the substantia nigra (2006) Arch Neurol, 63, pp. 584-588Alves, G., Wentzel-Larsen, T., Aarsland, D., Progression of motor impairment and disability in Parkinson's disease a population-based study (2005) Neurology, 65, pp. 1436-1441